Pharma Pulse 1/17/25: Telehealth, the Fully Hybridized Version, Why Pharma’s DTP Approach Should Be Applauded & more

Engaging Patients: Why Pharma’s Direct-to-Patient Approach Should Be Applauded

Physicians remain central even as DTP programs are implemented.

Telehealth, the Fully Hybridized Version | Prediction for 2025

Lyle Berkowitz, MD, CEO of KeyCare, gives a prediction for 2025.

OpenAI Courts Trump With Vision for ‘AI in America’

The maker of ChatGPT hopes to spur investment from the Middle East and avoid strict regulations on the development of new technologies.

WellSky® Launches Advanced AI-Powered Tool to Streamline Medication Reconciliation and Enhance Patient Care

WellSky announced the availability of WellSky Extract for Home Health, a powerful new tool that uses Artificial Intelligence to extract key information from patient-related documents and pictures of drug labels to populate data into the electronic health record (EHR), reducing manual documentation time, helping to ensure medication information is transferred accurately, and improving the patient and clinician experience.

ESPERO on LinkedIn

ACT: What are some technology trends we’ll see in clinical trials in 2025?

Kimberly Tableman hits on Data Interoperability in 90 seconds!

Thanks Applied Clinical Trials Magazinefor the mention.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs